Session Information

Filter Results:

Show Only CME Accredited Sessions

  • +

    IBS31 - Trial Design and Novel Drug Accessibility (Ticketed Session)

    • 07:00 - 08:00
    • 9/10/2019
    • Location: Amsterdam (2011)
    • IASLC CME Accredited
    • Type: Interactive Breakfast Session
    • Track: Targeted Therapy
    • +

      IBS31.01 - Endpoints and Trial Design for Oncogene Addicted NSCLC

      07:00 - 07:20  |  Presenter: Stefan Michiels

      • Abstract

      Loading...

    • +

      IBS31.02 - Novel Drug Access: Dream Versus Reality

      07:20 - 07:40  |  Presenter: Rafal Dziadziuszko

      • Abstract

      Loading...

    • +

      IBS31.03 - Q&A

      07:40 - 08:00

      • Abstract

      No abstract available for this presentation

  • +

    IS16 - Symposium by Novartis: The Road Ahead: New Horizons In The Treatment Of NSCLC (Not IASLC CME Accredited)

    • 07:00 - 08:00
    • 9/10/2019
    • Location: Hilton Head (1978)
    • Type: Industry Symposia & Workshops
    • Track:
  • +

    IS17 - Symposium by MSD: Prioritizing Lung Cancer: Strengthening Public Policy Responses To Unmet Needs (Not IASLC CME Accredited)

    • 07:00 - 08:00
    • 9/10/2019
    • Location: Barcelona (2005)
    • Type: Industry Symposia & Workshops
    • Track:
  • +

    WS06 - Women in Thoracic Oncology Networking Event

    • 07:00 - 08:00
    • 9/10/2019
    • Location: Copenhagen (1980)
    • Type: Workshop
    • Track: Thymoma/Other Thoracic Malignancies
    • +

      WS06.01 - Welcome

      07:00 - 07:05  |  Presenter: Enriqueta Felip, Narjust Duma, Angel Qin, Heather A Wakelee

      • Abstract

      No abstract available for this presentation

    • +

      WS06.02 - Lessons Learned – Women Leaders in Thoracic Oncology

      07:05 - 07:15  |  Presenter: Enriqueta Felip, Heather A Wakelee

      • Abstract

      No abstract available for this presentation

    • +

      WS06.03 - Networking Table 1: Mentor-Mentee Relationship

      07:15 - 07:15  |  Presenter: Heather A Wakelee

      • Abstract

      No abstract available for this presentation

    • +

      WS06.04 - Networking Table 2: How to Negotiate Successfully

      07:15 - 07:15  |  Presenter: Enriqueta Felip

      • Abstract

      No abstract available for this presentation

    • +

      WS06.05 - Networking Table 3: Early Career Investigators

      07:15 - 07:15  |  Presenter: Ticiana A. Leal

      • Abstract

      No abstract available for this presentation

    • +

      WS06.06 - Networking Table 4: Mid-Career Investigators

      07:15 - 07:15  |  Presenter: Nagla Karim

      • Abstract

      No abstract available for this presentation

    • +

      WS06.07 - Networking Table 5: Social Media and Networking

      07:15 - 07:15  |  Presenter: Narjust Duma, Angel Qin

      • Abstract

      No abstract available for this presentation

    • +

      WS06.08 - Networking Table 6: Work-Life Balance

      07:15 - 07:15  |  Presenter: Silvia Novello

      • Abstract

      No abstract available for this presentation

    • +

      WS06.09 - Networking Table 7: Life and Career Transitions

      07:15 - 07:15  |  Presenter: Miyako Satouchi

      • Abstract

      No abstract available for this presentation

    • +

      WS06.10 - Networking Table 8: Nursing in Thoracic Oncology

      07:15 - 07:15  |  Presenter: Anne Fraser

      • Abstract

      No abstract available for this presentation

    • +

      WS06.11 - Networking Table 9: I Am Done with My PhD, Now What?

      07:15 - 07:15  |  Presenter: Anne-Marie Baird

      • Abstract

      No abstract available for this presentation

    • +

      WS06.12 - Networking Table 10: Social Activism in Medicine

      07:15 - 07:15  |  Presenter: Deborah Doroshow, Lecia Sequist

      • Abstract

      No abstract available for this presentation

    • +

      WS06.13 - Networking Table 11: Time Management

      07:15 - 07:15  |  Presenter: Pilar Garrido

      • Abstract

      No abstract available for this presentation

  • +

    IASLC General Assembly

    • 08:00 - 08:45
    • 9/10/2019
    • Location: Tokyo (1982)
    • Type: General Assembly
    • Track:
  • +

    PL03 - Relevant Aspects of Lung Cancer Management

    • 09:15 - 10:45
    • 9/10/2019
    • Location: Barcelona (2005)
    • IASLC CME Accredited
    • Type: Plenary Session
    • Track: Advanced NSCLC
    • +

      PL03.01 - Establishing a Nurse Led Follow-Up Service for Patients With Resected Early Stage Lung Cancer

      09:15 - 09:35  |  Presenter: Jenny Mitchell  |  Author(s): Elizabeth Belcher

      • Abstract

      Loading...

    • +

      PL03.02 - Bringing Immunotherapy into the Curative Setting: Emerging Data on Neoadjuvant Strategies

      09:35 - 09:55  |  Presenter: Jamie E. Chaft

      • Abstract

      Loading...

    • +

      PL03.03 - The Disparity of Lung Cancer Prevention, Diagnosis and Treatment Around the World…What Is the Role of IASLC

      09:55 - 10:15  |  Presenter: Suresh S Ramalingam

      • Abstract

      Loading...

    • +

      PL03.04 - Lung Cancer and Tuberculosis: Parallel Lives

      10:15 - 10:35  |  Presenter: Tamas F Molnar

      • Abstract

      Loading...

    • +

      PL03.05 - Q&A

      10:35 - 10:45

      • Abstract

      No abstract available for this presentation

  • +

    PR04 - Press Conference

    • 10:45 - 11:30
    • 9/10/2019
    • Location: CC7.1 A&B
    • Type: Press Conference
    • Track:
    • +

      PR04.01 - Summary of Day's Plenary

      10:45 - 10:50

      • Abstract

      No abstract available for this presentation

    • +

      PR04.02 - KEYNOTE-024 3-Year Survival Update: Pembrolizumab vs Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer

      10:50 - 10:58

      • Abstract

      No abstract available for this presentation

    • +

      PR04.03 - IMpower131: Final OS Results of Carboplatin + Nab-Paclitaxel ± Atezolizumab in Advanced Squamous NSCLC

      10:58 - 11:06

      • Abstract

      No abstract available for this presentation

    • +

      PR04.03 - Five-Year Outcomes From the Randomized, Phase 3 Trials CheckMate 017/057: Nivolumab vs Docetaxel in Previously Treated NSCLC

      11:06 - 11:14

      • Abstract

      No abstract available for this presentation

    • +

      PR04.05 - Challenges in Lung Cancer Clinical Trials: A European Perspective

      11:14 - 11:22

      • Abstract

      No abstract available for this presentation

    • +

      PR04.06 - Establishing a Nurse Led Follow-Up Service for Patients With Resected Early Stage Lung Cancer

      11:22 - 11:30

      • Abstract

      No abstract available for this presentation

  • +

    ES23 - Optimal Management of N2 Disease in the Era Of IO

    • 11:30 - 13:00
    • 9/10/2019
    • Location: Hilton Head (1978)
    • IASLC CME Accredited
    • Type: Educational Session
    • Track: Treatment of Locoregional Disease - NSCLC
    • +

      Introduction/Poll

      11:30 - 11:30

      • Abstract

      No abstract available for this presentation

    • +

      ES23.01 - Mediastinoscopy with Invasive Staging: Are They Still Crucial?

      11:30 - 11:45  |  Presenter: Akif Turna

      • Abstract

      Loading...

    • +

      ES23.02 - Which N2 Patients Are Candidates to Surgery in the Era If I/O?

      11:45 - 12:00  |  Presenter: Eric Vallieres

      • Abstract

      Loading...

    • +

      ES23.03 - Is CT/RT Followed by I/O the Standard of Care for All N2 and Selected N3 Patients?

      12:00 - 12:15  |  Presenter: Wilfried Ernst Erich Eberhardt

      • Abstract

      Loading...

    • +

      ES23.04 - Optimal Supportive Care During and After Concurrent Chemoradiotherapy and I/O

      12:15 - 12:30  |  Presenter: Dirk De Ruysscher  |  Author(s): Kristiaan Nakaerts

      • Abstract

      Loading...

    • +

      ES23.05 - The Future of Systemic Therapy in Stage III

      12:30 - 12:45  |  Presenter: Pilar Garrido

      • Abstract

      Loading...

    • +

      ES23.06 - Q&A

      12:45 - 13:00

      • Abstract

      No abstract available for this presentation

  • +

    ES24 - Diagnosis and Management of Side Effects of Immunotherapy

    • 11:30 - 13:00
    • 9/10/2019
    • Location: Amsterdam (2011)
    • IASLC CME Accredited
    • Type: Educational Session
    • Track: Immuno-oncology
    • +

      ES24.01 - Recognizing Toxicities in an Early Phase in PDL1 Treatment

      11:30 - 11:50  |  Presenter: Hossein Borghaei

      • Abstract

      No abstract available for this presentation

    • +

      ES24.02 - Renal Toxicities in Combination I/O Chemotherapy Treatment

      11:50 - 12:10  |  Presenter: Joachim G.J.V. Aerts

      • Abstract

      No abstract available for this presentation

    • +

      ES24.03 - Management of Immunerelated Toxicities Unresponsive to Steroids

      12:10 - 12:30  |  Presenter: Anne Tsao

      • Abstract

      No abstract available for this presentation

    • +

      ES24.04 - Q&A

      12:30 - 13:00

      • Abstract

      No abstract available for this presentation

  • +

    MA18 - Advances in Diagnosis of Common Types of NSCLC

    • 11:30 - 13:00
    • 9/10/2019
    • Location: Tokyo (1982)
    • IASLC CME Accredited
    • Type: Mini Oral Session
    • Track: Pathology